Abstract
Background: Triple therapy involving a proton pump inhibitor and two antibiotics has been suggested as an effective treatment for Helicobacter pylori infection. The impact of imidazole resistance on the efficacy of such regimens is largely unknown.
Methods: One hundred patients with culture proven H. pylori infection were treated with omeprazole 40 mg b.d., amoxycillin 1000 mg b.d., and tinidazole 500 mg b.d., for one week. Pre-treatment imidazole susceptibility was measured by disk diffusion. Resistance was confirmed by E-test. Eradication was assessed by endoscopy 6-8 weeks after the end of treatment. In cases of doubt a 13C-urea breath test was performed. Side-effects were scored using a semiquantitative scale.
Results: H. pylori was eradicated in 95% of the patients with an imidazole-susceptible strain and in 69% of the patients with a resistant strain (P < 0.005). Significant side-effects were seen in 12%.
Conclusion: This proton pump inhibitor triple therapy is a simple, reasonably effective regimen with few significant side-effects. The efficacy is dependent on the susceptibility of the infecting H. pylori strain.
Original language | English |
---|---|
Pages (from-to) | 305-309 |
Number of pages | 5 |
Journal | Alimentary Pharmacology and Therapeutics |
Volume | 11 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1997 |
Externally published | Yes |
Access to Document
One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infectionFinal publisher's version, 137 KBLicence: Taverne
Handle.net
Other files and links
- See AlsoMôi Trường Quang HồngDoes Trichom*oniasis Cause Bumps? -Effectiveness of Helicobacter pylori Treatments According... : Official journal of the American College of Gastroenterology | ACGFamotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Thijs, J. C., Van Zwet, A. A., Thijs, W. J., Van Der Wouden, E. J. (1997). One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: The significance of imidazole resistance. Alimentary Pharmacology and Therapeutics, 11(2), 305-309. https://doi.org/10.1046/j.1365-2036.1997.155329000.x
Thijs, J. C. ; Van Zwet, A. A. ; Thijs, W. J. et al. / One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection : The significance of imidazole resistance. In: Alimentary Pharmacology and Therapeutics. 1997 ; Vol. 11, No. 2. pp. 305-309.
@article{2b92ad53ccba42d6bdc7985cd30c555b,
title = "One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: The significance of imidazole resistance",
abstract = "Background: Triple therapy involving a proton pump inhibitor and two antibiotics has been suggested as an effective treatment for Helicobacter pylori infection. The impact of imidazole resistance on the efficacy of such regimens is largely unknown.Methods: One hundred patients with culture proven H. pylori infection were treated with omeprazole 40 mg b.d., amoxycillin 1000 mg b.d., and tinidazole 500 mg b.d., for one week. Pre-treatment imidazole susceptibility was measured by disk diffusion. Resistance was confirmed by E-test. Eradication was assessed by endoscopy 6-8 weeks after the end of treatment. In cases of doubt a 13C-urea breath test was performed. Side-effects were scored using a semiquantitative scale.Results: H. pylori was eradicated in 95% of the patients with an imidazole-susceptible strain and in 69% of the patients with a resistant strain (P < 0.005). Significant side-effects were seen in 12%.Conclusion: This proton pump inhibitor triple therapy is a simple, reasonably effective regimen with few significant side-effects. The efficacy is dependent on the susceptibility of the infecting H. pylori strain.",
author = "Thijs, {J. C.} and {Van Zwet}, {A. A.} and Thijs, {W. J.} and {Van Der Wouden}, {E. J.} and A. Kooy",
year = "1997",
doi = "10.1046/j.1365-2036.1997.155329000.x",
language = "English",
volume = "11",
pages = "305--309",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley",
number = "2",
}
Thijs, JC, Van Zwet, AA, Thijs, WJ, Van Der Wouden, EJ 1997, 'One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: The significance of imidazole resistance', Alimentary Pharmacology and Therapeutics, vol. 11, no. 2, pp. 305-309. https://doi.org/10.1046/j.1365-2036.1997.155329000.x
One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: The significance of imidazole resistance. / Thijs, J. C.; Van Zwet, A. A.; Thijs, W. J. et al.
In: Alimentary Pharmacology and Therapeutics, Vol. 11, No. 2, 1997, p. 305-309.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection
T2 - The significance of imidazole resistance
AU - Thijs, J. C.
AU - Van Zwet, A. A.
AU - Thijs, W. J.
AU - Van Der Wouden, E. J.
AU - Kooy, A.
PY - 1997
Y1 - 1997
N2 - Background: Triple therapy involving a proton pump inhibitor and two antibiotics has been suggested as an effective treatment for Helicobacter pylori infection. The impact of imidazole resistance on the efficacy of such regimens is largely unknown.Methods: One hundred patients with culture proven H. pylori infection were treated with omeprazole 40 mg b.d., amoxycillin 1000 mg b.d., and tinidazole 500 mg b.d., for one week. Pre-treatment imidazole susceptibility was measured by disk diffusion. Resistance was confirmed by E-test. Eradication was assessed by endoscopy 6-8 weeks after the end of treatment. In cases of doubt a 13C-urea breath test was performed. Side-effects were scored using a semiquantitative scale.Results: H. pylori was eradicated in 95% of the patients with an imidazole-susceptible strain and in 69% of the patients with a resistant strain (P < 0.005). Significant side-effects were seen in 12%.Conclusion: This proton pump inhibitor triple therapy is a simple, reasonably effective regimen with few significant side-effects. The efficacy is dependent on the susceptibility of the infecting H. pylori strain.
AB - Background: Triple therapy involving a proton pump inhibitor and two antibiotics has been suggested as an effective treatment for Helicobacter pylori infection. The impact of imidazole resistance on the efficacy of such regimens is largely unknown.Methods: One hundred patients with culture proven H. pylori infection were treated with omeprazole 40 mg b.d., amoxycillin 1000 mg b.d., and tinidazole 500 mg b.d., for one week. Pre-treatment imidazole susceptibility was measured by disk diffusion. Resistance was confirmed by E-test. Eradication was assessed by endoscopy 6-8 weeks after the end of treatment. In cases of doubt a 13C-urea breath test was performed. Side-effects were scored using a semiquantitative scale.Results: H. pylori was eradicated in 95% of the patients with an imidazole-susceptible strain and in 69% of the patients with a resistant strain (P < 0.005). Significant side-effects were seen in 12%.Conclusion: This proton pump inhibitor triple therapy is a simple, reasonably effective regimen with few significant side-effects. The efficacy is dependent on the susceptibility of the infecting H. pylori strain.
UR - http://www.scopus.com/inward/record.url?scp=0030972411&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2036.1997.155329000.x
DO - 10.1046/j.1365-2036.1997.155329000.x
M3 - Article
C2 - 9146767
AN - SCOPUS:0030972411
SN - 0269-2813
VL - 11
SP - 305
EP - 309
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
IS - 2
ER -
Thijs JC, Van Zwet AA, Thijs WJ, Van Der Wouden EJ, Kooy A. One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: The significance of imidazole resistance. Alimentary Pharmacology and Therapeutics. 1997;11(2):305-309. doi: 10.1046/j.1365-2036.1997.155329000.x